GEN Exclusives

More »

GEN News Highlights

More »
Nov 6, 2007

DSM Pharmaceuticals Incorporates Formulation Development and CTM Manufacturing into Services

  • DSM Pharmaceuticals reports the expansion of its service offerings to include formulation development and clinical trial manufacturing (CTM) for solid dosage form products.

    “This expansion of services will have significant value-added benefits to our customers in terms of reducing cost and accelerating time to market as they will be able to avoid the high cost of tech transfers required for commercial launch by conducting development, CTM, and commercial manufacturing all at DSM’s Greenville, NC, facilities,” remarks Terry Novak, president and business unit director.

    DSM’s pharmaceutical development services will now include preformulation, analytical development, stability studies, formulation and reformulation development, controlled and modified release, controlled substances, clinical trial supply, and regulatory support.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?